Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.

Pharmaceuticals (Basel, Switzerland)

Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP.
PMID: 34208284
Pharmaceuticals (Basel). 2021 Jun 11;14(6). doi: 10.3390/ph14060560.

The rising use of designer benzodiazepines (DBZD) is a cat-and-mouse game between organized crime and law enforcement. Non-prohibited benzodiazepines are introduced onto the global drug market and scheduled as rapidly as possible by international authorities. In response, DBZD are...

Cite
Brunetti P, Giorgetti R, Tagliabracci A, et al. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel). 2021;14(6)doi: 10.3390/ph14060560.
Brunetti, P., Giorgetti, R., Tagliabracci, A., Huestis, M. A., & Busardò, F. P. (2021). Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel, Switzerland), 14(6), . https://doi.org/10.3390/ph14060560
Brunetti, Pietro, et al. "Designer Benzodiazepines: A Review of Toxicology and Public Health Risks." Pharmaceuticals (Basel, Switzerland) vol. 14,6 (2021). doi: https://doi.org/10.3390/ph14060560
Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel). 2021 Jun 11;14(6). doi: 10.3390/ph14060560. PMID: 34208284; PMCID: PMC8230725.
Copy Download .nbib Format: NLM
β-Polymorph of phenazepam: a powder study.

Acta crystallographica. Section E, Structure reports online

Sergeev GB, Sergeev BM, Morosov YN, Chernyshev VV.
PMID: 21587597
Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 25;66:o2623. doi: 10.1107/S1600536810037402.

THE TITLE COMPOUND [SYSTEMATIC NAME: 7-bromo-5-(2-chloro-phen-yl)-1H-1,4-benzodiazepin-2(3H)-one] (β-polymorph), C(15)H(10)BrClN(2)O, has been obtained via cryomodification of the known α-polymorph of phenazepam [Karapetyan et al. (1979 ▶). Bioorg. Khim.5, 1684-1690]. In both polymorphs, the mol-ecules, which differ only in the dihedral angles...

Cite
Sergeev GB, Sergeev BM, Morosov YN, et al. β-Polymorph of phenazepam: a powder study. Acta Crystallogr Sect E Struct Rep Online. 2010;66:o2623doi: 10.1107/S1600536810037402.
Sergeev, G. B., Sergeev, B. M., Morosov, Y. N., & Chernyshev, V. V. (2010). β-Polymorph of phenazepam: a powder study. Acta crystallographica. Section E, Structure reports online, 66o2623. https://doi.org/10.1107/S1600536810037402
Sergeev, Gleb B, et al. "β-Polymorph of phenazepam: a powder study." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): o2623. doi: https://doi.org/10.1107/S1600536810037402
Sergeev GB, Sergeev BM, Morosov YN, Chernyshev VV. β-Polymorph of phenazepam: a powder study. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 25;66:o2623. doi: 10.1107/S1600536810037402. PMID: 21587597; PMCID: PMC2983154.
Copy Download .nbib Format: NLM
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

Frontiers in pharmacology

Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P.
PMID: 26924987
Front Pharmacol. 2016 Feb 18;7:31. doi: 10.3389/fphar.2016.00031. eCollection 2016.

Clinical studies have shown the similarity of the spectrum of physiological effects of Selank and classical benzodiazepines, such as diazepam and phenazepam. These data suggest that there is a similar basis of their mechanism of action. To test this...

Cite
Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31doi: 10.3389/fphar.2016.00031.
Volkova, A., Shadrina, M., Kolomin, T., Andreeva, L., Limborska, S., Myasoedov, N., & Slominsky, P. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in pharmacology, 731. https://doi.org/10.3389/fphar.2016.00031
Volkova, Anastasiya, et al. "Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission." Frontiers in pharmacology vol. 7 (2016): 31. doi: https://doi.org/10.3389/fphar.2016.00031
Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016 Feb 18;7:31. doi: 10.3389/fphar.2016.00031. eCollection 2016. PMID: 26924987; PMCID: PMC4757669.
Copy Download .nbib Format: NLM
An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action.

Neuropsychiatric disease and treatment

Nuss P, Ferreri F, Bourin M.
PMID: 31308671
Neuropsychiatr Dis Treat. 2019 Jul 03;15:1781-1795. doi: 10.2147/NDT.S200568. eCollection 2019.

Treating the signs and symptoms of anxiety is an everyday challenge in clinical practice. When choosing between treatment options, anxiety needs to be understood in the situational, psychiatric, and biological context in which it arises. Etifoxine, a non-benzodiazepine anxiolytic...

Cite
Nuss P, Ferreri F, Bourin M. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action. Neuropsychiatr Dis Treat. 2019;15:1781-1795doi: 10.2147/NDT.S200568.
Nuss, P., Ferreri, F., & Bourin, M. (2019). An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action. Neuropsychiatric disease and treatment, 151781-1795. https://doi.org/10.2147/NDT.S200568
Nuss, Philippe, et al. "An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action." Neuropsychiatric disease and treatment vol. 15 (2019): 1781-1795. doi: https://doi.org/10.2147/NDT.S200568
Nuss P, Ferreri F, Bourin M. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action. Neuropsychiatr Dis Treat. 2019 Jul 03;15:1781-1795. doi: 10.2147/NDT.S200568. eCollection 2019. PMID: 31308671; PMCID: PMC6615018.
Copy Download .nbib Format: NLM
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.

Psychopharmacology bulletin

Zastrozhin MS, Efimova AV, Skryabin V, Smirnov VV, Petukhov AE, Pankratenko EP, Pozdniakov SA, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA.
PMID: 34887601
Psychopharmacol Bull. 2021 Nov 03;51(4):87-104.

INTRODUCTION: Phenazepam is commonly administered to patients diagnosed with major depressive disorder. Some proportion of such patients do not show adequate response to treatment regimen containing phenazepam, whereas many of them experience type A adverse drug reactions. Previous studies...

Cite
Zastrozhin MS, Efimova AV, Skryabin V, et al. Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacol Bull. 2021;51(4):87-104
Zastrozhin, M. S., Efimova, A. V., Skryabin, V., Smirnov, V. V., Petukhov, A. E., Pankratenko, E. P., Pozdniakov, S. A., Kaverina, E. V., Klepikov, D. A., Grishina, E. A., Ryzhikova, K. A., Bure, I. V., Bryun, E. A., & Sychev, D. A. (2021). Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacology bulletin, 51(4), 87-104.
Zastrozhin, M S, et al. "Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder." Psychopharmacology bulletin vol. 51,4 (2021): 87-104.
Zastrozhin MS, Efimova AV, Skryabin V, Smirnov VV, Petukhov AE, Pankratenko EP, Pozdniakov SA, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA. Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacol Bull. 2021 Nov 03;51(4):87-104. PMID: 34887601; PMCID: PMC8601761.
Copy Download .nbib Format: NLM
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder.

Psychopharmacology bulletin

Zastrozhin MS, Efimova AV, Skryabin V, Smirnov VV, Petukhov AE, Pankratenko EP, Pozdniakov SA, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA.
PMID: 34887601
Psychopharmacol Bull. 2021 Nov 03;51(4):87-104.

INTRODUCTION: Phenazepam is commonly administered to patients diagnosed with major depressive disorder. Some proportion of such patients do not show adequate response to treatment regimen containing phenazepam, whereas many of them experience type A adverse drug reactions. Previous studies...

Cite
Zastrozhin MS, Efimova AV, Skryabin V, et al. Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacol Bull. 2021;51(4):87-104
Zastrozhin, M. S., Efimova, A. V., Skryabin, V., Smirnov, V. V., Petukhov, A. E., Pankratenko, E. P., Pozdniakov, S. A., Kaverina, E. V., Klepikov, D. A., Grishina, E. A., Ryzhikova, K. A., Bure, I. V., Bryun, E. A., & Sychev, D. A. (2021). Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacology bulletin, 51(4), 87-104.
Zastrozhin, M S, et al. "Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder." Psychopharmacology bulletin vol. 51,4 (2021): 87-104.
Zastrozhin MS, Efimova AV, Skryabin V, Smirnov VV, Petukhov AE, Pankratenko EP, Pozdniakov SA, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA. Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder. Psychopharmacol Bull. 2021 Nov 03;51(4):87-104. PMID: 34887601; PMCID: PMC8601761.
Copy Download .nbib Format: NLM
Adaptation of Piglets Using Different Methods of Stress Prevention.

Animals : an open access journal from MDPI

Bekenev V, Garcia A, Hasnulin V.
PMID: 26479239
Animals (Basel). 2015 May 13;5(2):349-60. doi: 10.3390/ani5020349.

The purpose of this study was to evaluate the viability and growth rate of piglets after weaning, the content of lipids in the blood and liver, antioxidant activity (AOA) and lipid peroxidation (LPO) when various additives are used in...

Cite
Bekenev V, Garcia A, Hasnulin V. Adaptation of Piglets Using Different Methods of Stress Prevention. Animals (Basel). 2015;5(2):349-60doi: 10.3390/ani5020349.
Bekenev, V., Garcia, A., & Hasnulin, V. (2015). Adaptation of Piglets Using Different Methods of Stress Prevention. Animals : an open access journal from MDPI, 5(2), 349-60. https://doi.org/10.3390/ani5020349
Bekenev, Vitaly, et al. "Adaptation of Piglets Using Different Methods of Stress Prevention." Animals : an open access journal from MDPI vol. 5,2 (2015): 349-60. doi: https://doi.org/10.3390/ani5020349
Bekenev V, Garcia A, Hasnulin V. Adaptation of Piglets Using Different Methods of Stress Prevention. Animals (Basel). 2015 May 13;5(2):349-60. doi: 10.3390/ani5020349. PMID: 26479239; PMCID: PMC4494417.
Copy Download .nbib Format: NLM
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens.

Journal of addiction medicine

Garland JM, Hull JD, Bender CL, Marshall L, Holt AC.
PMID: 34172626
J Addict Med. 2021 Jun 23; doi: 10.1097/ADM.0000000000000884. Epub 2021 Jun 23.

OBJECTIVES: The illicit drug market continuously evolves, with new substances introduced to mimic prescription or other illicit drugs while evading detection by routine drug testing. The objective was to determine if designer benzodiazepines would be present in urine samples...

Cite
Garland JM, Hull JD, Bender CL, et al. Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens. J Addict Med. 2021;doi: 10.1097/ADM.0000000000000884.
Garland, J. M., Hull, J. D., Bender, C. L., Marshall, L., & Holt, A. C. (2021). Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens. Journal of addiction medicine, . https://doi.org/10.1097/ADM.0000000000000884
Garland, Jeneva M, et al. "Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens." Journal of addiction medicine vol. (2021). doi: https://doi.org/10.1097/ADM.0000000000000884
Garland JM, Hull JD, Bender CL, Marshall L, Holt AC. Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens. J Addict Med. 2021 Jun 23; doi: 10.1097/ADM.0000000000000884. Epub 2021 Jun 23. PMID: 34172626.
Copy Download .nbib Format: NLM
New uncontrolled benzodiazepine, phenazepam, emerging drug of abuse.

Innovations in clinical neuroscience

Oyemade A.
PMID: 23074694
Innov Clin Neurosci. 2012 Sep;9(9):10.

No abstract available.

Cite
Oyemade A. New uncontrolled benzodiazepine, phenazepam, emerging drug of abuse. Innov Clin Neurosci. 2012;9(9):10
Oyemade, A. (2012). New uncontrolled benzodiazepine, phenazepam, emerging drug of abuse. Innovations in clinical neuroscience, 9(9), 10.
Oyemade, Adegboyega. "New uncontrolled benzodiazepine, phenazepam, emerging drug of abuse." Innovations in clinical neuroscience vol. 9,9 (2012): 10.
Oyemade A. New uncontrolled benzodiazepine, phenazepam, emerging drug of abuse. Innov Clin Neurosci. 2012 Sep;9(9):10. PMID: 23074694; PMCID: PMC3472894.
Copy Download .nbib Format: NLM
Formation of Synthetically Versatile 2-Aminobenzophenones from Readily Accessed Acyl Hydrazides.

ACS omega

Ahmed N, Shamsabadi A, Chudasama V.
PMID: 31909344
ACS Omega. 2019 Dec 17;4(27):22601-22612. doi: 10.1021/acsomega.9b03417. eCollection 2019 Dec 31.

Herein, we report the transformation of readily accessed acyl hydrazides into protected 2-aminobenzophenones via a two-step process involving an aryne-based molecular rearrangement followed by a one-pot addition-elimination procedure. The assembly of the scaffold is tolerant of a wide variety...

Cite
Ahmed N, Shamsabadi A, Chudasama V. Formation of Synthetically Versatile 2-Aminobenzophenones from Readily Accessed Acyl Hydrazides. ACS Omega. 2019;4(27):22601-22612doi: 10.1021/acsomega.9b03417.
Ahmed, N., Shamsabadi, A., & Chudasama, V. (2019). Formation of Synthetically Versatile 2-Aminobenzophenones from Readily Accessed Acyl Hydrazides. ACS omega, 4(27), 22601-22612. https://doi.org/10.1021/acsomega.9b03417
Ahmed, Nehaal, et al. "Formation of Synthetically Versatile 2-Aminobenzophenones from Readily Accessed Acyl Hydrazides." ACS omega vol. 4,27 (2019): 22601-22612. doi: https://doi.org/10.1021/acsomega.9b03417
Ahmed N, Shamsabadi A, Chudasama V. Formation of Synthetically Versatile 2-Aminobenzophenones from Readily Accessed Acyl Hydrazides. ACS Omega. 2019 Dec 17;4(27):22601-22612. doi: 10.1021/acsomega.9b03417. eCollection 2019 Dec 31. PMID: 31909344; PMCID: PMC6941372.
Copy Download .nbib Format: NLM
Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood.

Journal of analytical toxicology

Mastrovito R, Trail C, Lino M, Cervantes A, Chan-Hosokawa A, Strathmann F, Logan B.
PMID: 34791285
J Anal Toxicol. 2021 Nov 16; doi: 10.1093/jat/bkab110. Epub 2021 Nov 16.

The purpose of this study was to examine the impact of 59 novel psychoactive compounds on common enzyme-linked immunosorbent assay (ELISA) testing kits. Concentrations above and below the individual kit reporting limits in each class were measured. Compounds that...

Cite
Mastrovito R, Trail C, Lino M, et al. Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood. J Anal Toxicol. 2021;doi: 10.1093/jat/bkab110.
Mastrovito, R., Trail, C., Lino, M., Cervantes, A., Chan-Hosokawa, A., Strathmann, F., & Logan, B. (2021). Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood. Journal of analytical toxicology, . https://doi.org/10.1093/jat/bkab110
Mastrovito, Rebecca, et al. "Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood." Journal of analytical toxicology vol. (2021). doi: https://doi.org/10.1093/jat/bkab110
Mastrovito R, Trail C, Lino M, Cervantes A, Chan-Hosokawa A, Strathmann F, Logan B. Determination of Cross-Reactivity of Novel Psychoactive Substances with Drug Screen Immunoassays Kits in Whole Blood. J Anal Toxicol. 2021 Nov 16; doi: 10.1093/jat/bkab110. Epub 2021 Nov 16. PMID: 34791285.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries